Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1979 Feb;76(2):829–832. doi: 10.1073/pnas.76.2.829

Sodium ascorbate potentiates the growth inhibitory effect of certain agents on neuroblastoma cells in culture.

K N Prasad, P K Sinha, M Ramanujam, A Sakamoto
PMCID: PMC383064  PMID: 284405

Abstract

Mouse neuroblastoma (NB) cells in culture were more sensitive to sodium L-ascorbate than were rat glioma cells by the criterion of growth inhibition (due to cell death and reduction in cell division). Sodium L-ascorbate at nonlethal concentrations potentiated the effect of 5-fluorouracil (FUra), x-irradiation, bleomycin, RO20-1724, prostaglandin E1, and sodium butyrate on NB cells but did not produce such an effect on glioma cells. Sodium L-ascorbate did not enhance the effect of vincristine, 6-thioguanine, or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) except at higher drug doses and it reduced the cytotoxic effect of methotrexate and 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) on NB cells. Sodium D-ascorbate produced effects similar to those produced by sodium L-ascorbate on NB cells. L-Ascorbic acid-2-sulfate (barium salt) affected neither the growth rate nor the effect of 5-FUra on NB cells. Glutathione, a reducing agent, was more toxic to NB cells in comparison to D- OR L-ascorbate; however, at a similar concentration it failed to potentiate the effect of 5-FUra on NB cells.

Full text

PDF
829

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong D., Van Wormer D., Dimmitt S. Decreased amniotic fluid peroxidase in malignancy of the cervix. Cancer Biochem Biophys. 1977;2(1):1–4. [PubMed] [Google Scholar]
  2. Benade L., Howard T., Burk D. Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-1,2,4,-triazole. Oncology. 1969;23(1):33–43. doi: 10.1159/000224465. [DOI] [PubMed] [Google Scholar]
  3. Benda P., Lightbody J., Sato G., Levine L., Sweet W. Differentiated rat glial cell strain in tissue culture. Science. 1968 Jul 26;161(3839):370–371. doi: 10.1126/science.161.3839.370. [DOI] [PubMed] [Google Scholar]
  4. Breton-Gorius J., Houssay D., Dreyfus B. Partial myeloperoxidase deficiency in a case of preleukaemia. I. Studies of fine structure and peroxidase synthesis of promyelocytes. Br J Haematol. 1975 Jul;30(3):273–278. doi: 10.1111/j.1365-2141.1975.tb00542.x. [DOI] [PubMed] [Google Scholar]
  5. Cameron E., Campbell A. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact. 1974 Oct;9(4):285–315. doi: 10.1016/0009-2797(74)90019-2. [DOI] [PubMed] [Google Scholar]
  6. Cameron E., Pauling L. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A. 1976 Oct;73(10):3685–3689. doi: 10.1073/pnas.73.10.3685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cameron E., Pauling L. The orthomolecular treatment of cancer. I. The role of ascorbic acid in host resistance. Chem Biol Interact. 1974 Oct;9(4):273–283. doi: 10.1016/0009-2797(74)90018-0. [DOI] [PubMed] [Google Scholar]
  8. Catovsky D., Galton D. A., Robinson J. Myeloperoxidase-deficient neutrophils in acute myeloid leukaemia. Scand J Haematol. 1972;9(2):142–148. doi: 10.1111/j.1600-0609.1972.tb00923.x. [DOI] [PubMed] [Google Scholar]
  9. Jacob H. S., Lux S. E., 4th Degradation of membrane phospholipids and thiols in peroxide hemolysis: studies in vitamin E deficiency. Blood. 1968 Oct;32(4):549–568. [PubMed] [Google Scholar]
  10. MOHBERG J., JOHNSON M. J. STABILITY OF VITAMINS IN A CHEMICALLY DEFINED MEDIUM FOR 929-L FIBROBLASTS. J Natl Cancer Inst. 1963 Sep;31:603–610. [PubMed] [Google Scholar]
  11. Orr C. W. Studies on ascorbic acid. I. Factors influencing the ascorbate-mediated inhibition of catalase. Biochemistry. 1967 Oct;6(10):2995–3000. doi: 10.1021/bi00862a004. [DOI] [PubMed] [Google Scholar]
  12. Peterkofsky B., Prather W. Cytotoxicity of ascorbate and other reducing agents towards cultured fibroblasts as a result of hydrogen peroxide formation. J Cell Physiol. 1977 Jan;90(1):61–70. doi: 10.1002/jcp.1040900109. [DOI] [PubMed] [Google Scholar]
  13. Peterkofsky B. The effect of ascorbic acid on collagen polypeptide synthesis and proline hydroxylation during the growth of cultured fibroblasts. Arch Biochem Biophys. 1972 Sep;152(1):318–328. doi: 10.1016/0003-9861(72)90221-4. [DOI] [PubMed] [Google Scholar]
  14. Prasad K. N. Differentiation of neuroblastoma cells in culture. Biol Rev Camb Philos Soc. 1975 May;50(2):129–165. doi: 10.1111/j.1469-185x.1975.tb01055.x. [DOI] [PubMed] [Google Scholar]
  15. Smolen J. E., Shohet S. B. Permeability changes induced by peroxidation in liposomes prepared from human erythrocyte lipids. J Lipid Res. 1974 May;15(3):273–280. [PubMed] [Google Scholar]
  16. Strauss R. R., Paul B. B., Selvaraj R. J., Sbarra A. J. A peroxidase inhibitor in leukemic AKR mouse spleen cells. Cancer Res. 1974 Dec;34(12):3220–3224. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES